| Breakdown | TTM | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.61M | 118.43M | 51.48M | 32.45M | 23.05M | 4.50M |
| Gross Profit | 0.00 | 118.40M | 7.43M | 32.45M | 23.05M | 4.50M |
| EBITDA | 105.39M | 104.69M | 43.48M | 27.68M | 19.76M | 14.03M |
| Net Income | 104.43M | 99.50M | 42.53M | 23.84M | 17.48M | 13.72M |
Balance Sheet | ||||||
| Total Assets | 363.14M | 340.88M | 238.30M | 197.77M | 171.11M | 153.01M |
| Cash, Cash Equivalents and Short-Term Investments | 52.58M | 74.14M | 40.51M | 11.56M | 8.63M | 709.00K |
| Total Debt | 315.00K | 412.00K | 596.00K | 771.00K | 939.00K | 2.10M |
| Total Liabilities | 13.63M | 14.47M | 9.13M | 8.23M | 4.51M | 3.11M |
| Stockholders Equity | 349.50M | 326.41M | 229.17M | 189.54M | 166.61M | 149.91M |
Cash Flow | ||||||
| Free Cash Flow | -13.37M | 33.43M | -18.72M | -646.00K | 17.48M | 2.44M |
| Operating Cash Flow | -13.30M | 33.49M | -18.70M | -635.00K | 17.48M | 2.44M |
| Investing Cash Flow | -5.48M | 25.00K | 50.87M | -515.00K | -6.00K | -2.41M |
| Financing Cash Flow | -8.86M | 190.00K | -3.21M | -1.23M | -2.12M | -25.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | £229.89M | 2.03 | 30.90% | 3.21% | 165.25% | 95.32% | |
76 Outperform | £189.77M | 4.34 | 12.06% | 8.15% | 1.29% | 11.17% | |
72 Outperform | £207.67M | 13.32 | 7.58% | 5.14% | -13.29% | 63.87% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £116.86M | 21.20 | 1.79% | 3.29% | -9.37% | ― | |
64 Neutral | £146.57M | 11.47 | 9.72% | 21.31% | -15.65% | -12.27% | |
62 Neutral | £147.76M | 11.98 | 17.51% | 17.93% | -16.53% | -44.15% |